We have previously suggested that the decrease in the levels of serum total thyroxine (T 4 ) and free T 4 by a single administration to rats of Kanechlor-500 (KC500) at a dose of 100 mg/kg is not necessarily dependent on the increase in hepatic T 4 -UDP-glucuronosyltransferase (UDP-GT). In the present study, we determined whether or not a consecutive treatment with KC500 at a relatively low dose (10 mg/kg i.p., once daily for 10 days) results in a decrease in the level of serum total T 4 and further investigated an exact mechanism for the KC500-induced decrease in the T 4 . At 4 days after final treatment with KC500, the serum total T 4 and free T 4 levels were markedly decreased in both Wistar and UGT1A-deficient Wistar (Gunn) rats, whereas significant increases in hepatic T 4 -UDP-GT activity were observed in 
I]T 4 administered to the KC500-pretreated Wistar and Gunn rats was faster than that to the corresponding control (KC500-untreated) rats. The accumulated level of [ 125 I]T 4 was increased in several tissues, especially the liver, in the KC500-pretreated rats. The present findings demonstrated that a consecutive treatment with KC500 resulted in a significant decrease in the level of serum total T 4 in both Wistar and Gunn rats and further indicated that the KC500-induced decrease would occur through increase in accumulation of T 4 in several tissues, especially the liver, rather than increase in hepatic T 4 -UDP-GT activity.
Most polychlorinated biphenyls (PCBs) are known to decrease the level of serum thyroid hormone and to increase the activity of hepatic drug-metabolizing enzymes in rats (Van Birgelen et al., 1995; Craft et al., 2002) . As possible mechanisms for the PCBinduced decrease in the level of serum thyroid hormone, enhancement of thyroid hormone metabolism by PCB and displacement of the hormone from serum transport proteins, including transthyretin (TTR), by PCB and its ring-hydroxylated metabolites are considered Klaassen, 1992a, 1994; Brouwer et al., 1998) . In particular, the decrease in the level of serum thyroxine (T 4 ) by 3,3Ј,4,4Ј,5-pentachlorobiphenyl, Aroclor 1254, and 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats is believed to occur mainly through induction of the UDP-glucuronosyltransferases (UDP-GTs), especially UGT1A subfamily enzymes, responsible for glucuronidation of T 4 (Barter and Klaassen, 1994; Van Birgelen et al., 1995) .
However, the magnitude of decrease in the level of serum total T 4 is not necessarily correlated with that of increase in T 4 -UDP-GT activity (Craft et al., 2002; Hood et al., 2003) . Furthermore, we have reported that in Kanechlor-500 (KC500)-treated mice, serum T 4 level decreased without an increase in T 4 -UDP-GT activity (Kato et al., 2003) and that the decrease in serum total T 4 level by a single administration of either KC500 or 2,2Ј,4,5,5Ј-pentachlorobiphenyl occurred even in UGT1A-deficient Wistar (Gunn) rats (Kato et al., 2004) . Thus, an exact mechanism for the PCB-induced decrease in the level of serum thyroid hormone remains unclear. To date, most studies on biological effects of PCB have been performed using experimental animals treated once at a high dose (more than 100 mg/kg body weight), and the effect of the consecutive treatment at a low dose has been little reported. Humans and wild animals are exposed to a wide variety of environmental chemicals, including PCB, at a low level over a long period of time. Therefore, a study on biological effects by consecutive treatment with PCB at a low dose would be very important.
In the present study, therefore, we examined whether or not a consecutive treatment with KC500 at a relatively low dose (10 mg/kg i.p., once daily for 10 days) results in decrease in the level of serum total T 4 and further discussed a mechanism underlying the PCBinduced decrease in the T 4 .
Materials and Methods
Chemicals. Panacete 810 (medium-chain triglycerides) was purchased from Nippon Oils and Fats Co. Ltd. (Tokyo, Japan). The [ 125 I]T 4 , radiolabeled at the 5Ј-position of the outer ring, was obtained from PerkinElmer Life and Analytical Sciences (Waltham, MA). The KC500 used in the present experiments contains 2,2Ј,5,5Ј-tetrachlorobiphenyl (5.6% of total PCBs), 2,2Ј,3,5Ј,6-pentachlorobiphenyl (6.5%), 2,2Ј,4,5,5Ј-pentachlorobiphenyl (10%), 2,3,3Ј,4Ј,6-pentachlorobiphenyl (7.4%), 2,3Ј,4,4Ј,5-pentachlorobiphenyl (7.7%), 2,2Ј,3,4,4Ј,5Ј-hexachlorobiphenyl (5.6%), and 2,2Ј,4,4Ј,5,5Ј-hexachlorobiphenyl (5.4%) as major PCB congeners (Haraguchi et al., 2005) . All the other chemicals used herein were obtained commercially in appropriate grades of purity.
Animal Treatments. Male Wistar rats (160 -200 g) and UGT1A-deficient Wistar rats (Gunn rats, were obtained from Japan SLC., Inc. (Shizuoka, Japan). Male Wistar and Gunn rats were housed three or four per cage with free access to commercial chow and tap water, maintained on a 12-h dark/light cycle (8:00 AM to 8:00 PM light) in an air-controlled room (temperature, 24.5 Ϯ 1°C; humidity, 55 Ϯ 5%), and handled with human care under the guidelines of the University of Shizuoka (Shizuoka, Japan). Rats received consecutive intraperitoneal injections of KC500 (10 mg/kg) dissolved in Panacete 810 (5 ml/kg) at 24-h intervals for 10 days. Control animals were treated with vehicle alone (5 mg/kg).
In Vivo Study. Rats were killed by decapitation 4 days after the final administration of KC500. The liver was removed, and hepatic microsomes were prepared according to the method of Kato et al. (1995) and stored at Ϫ85°C until use. Blood was collected from each animal between 10:30 and 11:30 AM. After clotting at room temperature, serum was separated by centrifugation and stored at Ϫ50°C until use. 
Effects of KC500 on levels of serum total T 4 , free T 4 , total T 3 , and TSH in Wistar and Gunn rats. Animals were killed 4 days after the final administration of KC500 (10 mg/kg i.p., once daily for 10 days), and levels of serum thyroid hormones were measured as described under Materials and Methods. Constitutive levels: total T 4 , 4.29 Ϯ 0.38 (Wistar, n ϭ 5) and 5.80 Ϯ 0.32 g/dl (Gunn, n ϭ 5); free T 4 , 2.17 Ϯ 0.16 (Wistar, n ϭ 5) and 2.71 Ϯ 0.17 ng/dl (Gunn, n ϭ 5); total T 3 , 0.34 Ϯ 0.03 (Wistar, n ϭ 6) and 0.96 Ϯ 0.05 ng/ml (Gunn, n ϭ 4); TSH, 4.89 Ϯ 0.33 (Wistar, n ϭ 5) and 7.48 Ϯ 1.14 ng/ml (Gunn, n ϭ 5). Each column represents the mean Ϯ S.E. (vertical bars) for five to six animals. ‫,ء‬ P Ͻ 0.01, significantly different from each control. 
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Analysis of serum hormones. Levels of total T 4 , free T 4 , total triiodothyronine (T 3 ), and thyroid-stimulating hormone (TSH) were measured by radioimmunoassay using Total T4 and Free T4 kits (Diagnostic Products Corporation, Los Angels, CA), the Triiodothyronine kit GammaCoat T 3 II (DiaSorin Inc., Stillwater, MN), and the rTSH [
125 I] Biotrak assay system (GE Healthcare UK, Ltd., Little Chalfont, Buckinghamshire, UK), respectively.
Hepatic microsomal enzyme assays. Hepatic microsomal fraction was prepared according to the method described previously (Kato et al., 1995) , and the amount of hepatic microsomal protein was determined by the method of Lowry et al. (1951) with bovine serum albumin as a standard. Microsomal Odealkylase activities of 7-benzyloxy-, 7-ethoxy-, and 7-pentoxyresorufins were determined by the method of Burke et al. (1985) .
Hepatic T 4 -metabolizing enzyme assay. The activity of microsomal UDP-GT toward T 4 (T 4 -UGT activity) was determined by the methods of Barter and Klaassen (1992b) .
Western blot analysis. The polyclonal anti-peptide antibodies against the common region of UGT1A isoforms and specific antibodies against UGT1A1, UGT1A6, and UGT2B1, which were established by Ikushiro et al. (1995 Ikushiro et al. ( , 1997 , were used. Western blot analyses for microsomal UGT isoforms were performed by the method of Luquita et al. (2001) . The bands corresponding to UGT1A1, UGT1A6, and UGT2B1 on a sheet were detected using chemical luminescence (ECL detection kit; GE Healthcare UK, Ltd.), and the level of each protein was determined densitometrically with LAS-1000 (Fuji Photo Film. Co., Ltd., Tokyo, Japan).
Ex Vivo Study. At 4 days after a consecutive 10-day treatment with KC500, the rats were anesthetized with a saline (2 ml/kg) containing sodium pentobarbital (25 mg/ml) and potassium iodide (1 mg/ml). The femoral artery was cannulated (polyethylene tube SP31; Natsume Inc., Tokyo, Japan) and primed with heparinized saline (33 units/ml), and then the animal's body was warmed to 37°C. Fifteen minutes later, the rats were given i.v. 1 ml of [ 125 I]T 4 (15 Ci /ml) dissolved in the saline containing 10 mM NaOH and 1% normal rat serum.
Clearance Davis et al. (1970) . In brief, serum was diluted in 100 mM phosphate buffer (pH 7.4) containing 1 mM EDTA, 1 mM dithiothreitol, and 30% glycerol, and subjected to electrophoresis on 4 to 20% gradient native polyacrylamide gels PAG Mid "Daiichi" 4/20 (Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan). The electrophoresis was performed at 4°C for 11 h at 20 mA in the 0.025 M Tris buffer (pH 8.4) containing 0.192 M glycine. The human albumin and TTR, which were incubated with [
125 I]T 4 , were also applied on the gel as templates. After the electrophoresis, a gel was dried and radioautographed for 20 h at room temperature using Imaging Plate 2040 (Fuji Photo Film Co., Ltd. Oppenheimer et al. (1968) . In brief, at 60 min after administration of [ 125 I]T 4 to KC500-pretreated rats, blood was sampled from abdominal aorta. Then, cerebrum, cerebellum, pituitary gland, thyroid gland, sublingual gland, submandibular gland, thymus, heart, lung, liver, kidney, adrenal gland, spleen, pancreas, testis, prostate gland, seminal vesicle, stomach, duodenum, jejunum, ileum, cecum, brown fat, skeletal muscle, bone marrow skin, spinal cord, and fat were removed and weighed. Radioactivities in serum and the tissues were determined by a gamma-counter (COBRA II AUTO-GAMMA5002; PerkinElmer Life and Analytical Sciences), and amounts of [ 125 I]T 4 in various tissues were shown as ratios of tissue to serum.
Statistics. The data obtained were statistically analyzed according to Stu- were estimated with noncompartmental methods as described previously (Tabata et al., 1999) .
Results
Serum Hormone Levels. Effects of KC500 on levels of serum thyroid hormones were examined in Wistar and Gunn rats (Fig. 1) . In both Wistar and Gunn rats, KC500 treatment resulted in decreases of the serum total T 4 and free T 4 , and the magnitude of the decrease in each serum thyroid hormone was almost the same in both strains of rats. On the other hand, a significant decrease in the level of serum total T 3 was observed in Gunn rats but not in Wistar rats. In addition, no significant change in TSH level was observed in either Wistar or Gunn rats.
Hepatic Drug-Metabolizing Enzymes. Effects of KC500 on hepatic microsomal activities of benzyloxyresorufin O-dealkylase (CYP2B1/2 and CYP3A1/2), pentoxyresorufin O-dealkylase (CYP2B1/2), and ethoxyresorufin O-dealkylase (CYP1A1/2) were examined in Wistar and Gunn rats. In both Wistar and Gunn rats, these enzyme activities were significantly increased by KC500 (Table  1) , and the increase in each enzyme activity was much greater in Wistar rats than in Gunn rats.
Hepatic T 4 -Metabolizing Enzyme Activities. T 4 glucuronidation is primarily mediated by hepatic T 4 -UDP-GTs, such as UGT1A1 and UGT1A6, in the rat liver (Visser, 1996) , and a chemical-mediated induction of the enzymes is considered to contribute to the decrease in the level of serum total T 4 . Therefore, we examined effects of KC500 on hepatic microsomal T 4 -UDP-GT activity in Wistar and Gunn rats. Constitutive activity of T 4 -UDP-GT was approximately 2.2-fold higher in Wistar rats than in Gunn rats. Treatment with KC500 resulted in significant increase of T 4 -UDP-GT activity in Wistar rats but not in Gunn rats (Fig. 2) .
Western Blot Analysis for UGT1As. Levels of the proteins responsible for UGT1A enzymes, UGT1A1 and UGT1A6, were increased by KC500 treatment in Wistar rats but not in Gunn rats (Figs.  3 and 4) . In addition, no expression of the UGT1A enzymes was confirmed in Gunn rats. On the other hand, the level of UGT2B1 was significantly increased by KC500 in both Wistar and Gunn rats, and magnitudes of the increase in both strains of rats were almost the same (Figs. 3 and 4 (Fig. 7) were summarized in Table 2 . The mean total body clearances (CL tb ) of [ 125 I]T 4 in the KC500-pretreated rats were 2.4 and 2.9 times, respectively, greater than those in the corresponding control rats. The steady-state volumes of distribution (Vd ss ) in the KC500-pretreated rats were 1.6 and 2.4 times, respectively, larger than those in the corresponding control rats. Figs. 8 and 9 , respectively. K p values of the thyroid gland and liver were the greatest among those of the tissues examined in either Wistar or Gunn rats (Fig. 8) . In addition, K p values in all the tissues examined, with the exception of the testis and ileum, were greater in KC500-pretreated Wistar rats than those in the corresponding control (KC500-untreated) rats. K p values in the thyroid gland, liver, and jejunum in the KC500-pretreated Wistar and Gunn rats were 1.6 to 1.8, 3.3 to 3.8, and 4.7 to 11.5 times, respectively, higher than those in corresponding control rats (Fig. 8) .
In the control Wistar and Gunn rats, the accumulation level of [ 125 I]T 4 was highest in the liver, among the tissues examined (Fig. 9) . In both Wistar and Gunn rats, pretreatment with KC500 resulted in an increase in the accumulation level in the liver, and the levels increased to more than 40% of the [ 125 I]T 4 dosed (Fig. 9) . Likewise, significant increase in accumulation of [ 125 I]T 4 was observed in the jejunum (Fig.  9) . In addition, significant increases in the liver weight and accumulation level (per g liver) of [
125 I]T 4 occurred in KC500-pretreated Wistar rats, but not in Gunn rats (Tables 3 and 4) .
Discussion
In the present study, we found that consecutive treatment with KC500 (10 mg/kg i.p., once daily for 10 days; total dose, 100 mg/kg) promoted accumulation of T 4 in several tissues, especially the liver, and resulted in a drastic decrease in the levels of serum total T 4 and free T 4 in both Wistar and Gunn (UGT1A-deficient) rats. Thus, a decrease in the level of serum total T 4 is also observed in the Wistar and Gunn rats treated with KC500 (a single i.p. administration at a dose of 100 mg/kg) (Kato et al., 2004) . In addition, constitutive levels of serum total T 4 and T 3 were higher in Gunn rats than in Wistar rats, and the results were identified with those as previously described by Benathan et al. (1983) . The difference in constitutive level of serum thyroid hormone between Wistar and Gunn rats seems to be dependent on differences in the level and/or activity of T 4 /T 3 -UDP-GTs.
As a possible explanation for a chemical-induced decrease in serum thyroid hormones, a hepatic T 4 -UDP-GT-dependent mechanism is generally considered, because T 4 -UDP-GT inducers, including PCB, phenobarbital, 3-methylcholanthrene, pregnenolone-16␣-carbonitrile, and clobazam, show strong activities for decreasing the level of serum total thyroid hormones, including T 4 and T 3 (Barter and Klaassen, 1994; Van Birgelen et al., 1995; Miyawaki et al., 2003) . However, among the experimental animals treated with a T 4 -UDP-GT inducer, the difference in magnitude of decrease in the level of serum total T 4 is not necessarily correlated with that of hepatic T 4 -UDP-GT activity (Craft et al., 2002; Hood et al., 2003; Kato et al., 2003) . Our present and previous results (Kato et al., 2004 using Wistar and Gunn rats support a hypothesis that significant decrease in the level of serum total thyroid hormones by either PCB or phenobarbital occurs primarily in a hepatic T 4 -UDP-GT-independent pathway.
As a possible mechanism for the PCB-induced decrease in serum T 4 level, an increase in hepatic drug-metabolizing enzymes might be considered. However, these are induced to a greater extent in the Wistar rats than in the Gunn rats, whereas magnitudes of decrease in serum T 4 level in Wistar and Gunn rats were almost the same. Accordingly, the KC500-induced decrease in serum T 4 level is thought to be independent of the KC500-induced drug-metabolizing enzymes, including UDT-GTs and cytochromes P450. As the factors regulating the level of serum total T 4 , serum TSH, hepatic type I iodothyronine deiodinase, and TTR are known. However, no significant change in the level of serum TSH occurs in the PCBtreated rats (Liu et al., 1995; Hood et al., 1999; Hallgren et al., 2001; Kato et al., 2004) . Hepatic type I iodothyronine deiodinase activity was significantly decreased in Wistar and Gunn rats by KC500 (Kato et al., 2004) . On the other hand, a TTR-associated pathway might be considered as an explanation for the PCB-induced decrease in the level of serum total 
to the KC500-pretreated Wistar and Gunn rats
The experimental conditions were the same as those described in Fig. 7 . The values shown are expressed as the mean Ϯ S.E. for four to seven animals. T 4 , because PCB and its ring-hydroxylated metabolites act as T 4 antagonists to TTR (Lans et al., 1993; Brouwer et al., 1998; Meerts et al., 2002; Kato et al., 2004 125 I]T 4 were observed in the KC500-pretreated rats. A tissue-to-serum concentration ratio (K p value) was greater in several tissues, especially the liver, of the KC500-pretreated Wistar and Gunn rats than in the corresponding control (KC500-untreated) rat tissues. In addition, in both KC500-pretreated Wistar and Gunn rats, more than 40% of the [ 125 I]T 4 dosed was accumulated in the liver.
Animal
In conclusion, the present findings confirmed that PCB-induced decrease in serum T 4 occurs not only in Wistar rats but also in Gunn (UGT1A-deficient) rats and further led to a hypothesis that the PCBinduced decrease occurs through increase in accumulation (transportation from serum to liver) of T 4 in the liver, rather than through induction of hepatic T 4 -UDP-GT. In addition, the increased accumulation in the liver might be attributed to the PCB-and its metabolite(s)-mediated inhibition of formation of serum T 4 -TTR complex. 
TABLE 3
Liver weights after the administration of KC500 to Wistar and Gunn rats Animals were killed at 4 days after the final administration of KC500 (10 mg/kg i.p., once daily for 10 days). The values shown are expressed as the mean Ϯ S.E. for four to six animals. 
Animal

in the KC500-pretreated Wistar and Gunn rat livers
The experimental conditions were the same as those described in Fig. 8 . The values shown are expressed as the mean Ϯ S.E. for four to six animals. 
